Medtronic, Inc. has announced the U.S. launch of its Export Advance aspiration catheter, which it says offers greater power and superior deliverability in coronary artery thrombus removal.
Medtronic’s Export Advance thrombectomy catheter gained CE mark approval in May of this year and was more recently cleared by the U.S. FDA.
The latest addition to Medtronic’s portfolio of thrombectomy devices, Export Advance features a pre-loaded stylet that the company says increases the deliverability and kink resistance while traversing the vasculature to reach the aspiration site.
To further optimize performance, the Export Advance aspiration catheter is also constructed with full-wall variable braiding technology, which provides variable degrees of stiffness along the length of the device to enhance flexibility and pushability while navigating the device through the vasculature.
“With the Export Advance aspiration catheter, Medtronic has taken the power and deliverability of manual thrombectomy devices to a new level,” said Dr. Hoang Thai, an associate professor of medicine and associate program director of the interventional cardiology fellowship at the University of Arizona.
“With more than 10 years of market leadership in this product category, Medtronic has continued to lead the way in innovation, setting a new standard of performance with the Export Advance aspiration catheter,” said Jason Weidman, vice president and general manager of Medtronic’s coronary business. “In addition to superior deliverability, our next-generation device offers high-performing aspiration power that physicians have come to expect from Export aspiration catheters, which to date have been used to treat more than one million patients worldwide.”
Source: Medtronic, Inc.